Abstract:Background: Curcumin (CUR) has been linked with antioxidant, anti-inflammatory, antimicrobial, anti amyloid, and antitumor effects, but its application is limited because of its low aqueous solubility and poor oral bioavailability. Methods: To improve its bioavailability and water solubility, we synthesized two series of poly (epsilon-Caprolactone)-poly (ethylene glycol)-poly (epsilon-Caprolactone) triblock copolymers by ring-opening polymerization of poly (ethylene glycol) and epsilon-Caprolactone, with stannous 2-ethylhexanoate as the catalyst. Structure of the copolymers was characterized by proton nuclear magnetic resonance spectroscopy, Fourier transform infrared spectroscopy, and gel permeation chromatography. The nanoparticles (NPs) were prepared using a probe-type ultrasonic emulsion and solvent evaporation method. To obtain an optimal delivery system, we explored the effect of the length of the copolymers' hydrophilic and hydrophobic chains on the encapsulation of hydrophobic CUR, performing entrapment efficiency and drug loading evaluations, as well as studying the particle distribution and in vitro release using the direct dispersion method. Finally, study of the in vivo pharmacokinetics of the CUR-loaded NPs was also carried out on selected copolymers in comparison with CUR solution formulations. Results: CUR was encapsulated with 94.3% and 95.5% efficiency in biodegradable nanoparticulate formulations based on NP43 and NP63, respectively. Dynamic laser light scattering and transmission electron microscopy indicated a particle diameter of 55.6 nm and 62.4 nm for NP43 and NP63, respectively. Fourier transform infrared spectroscopy and differential scanning calorimetry analysis of the NPs showed that CUR was encapsulated into the NPs. The in vitro release experiments showed that NP63 controlled the release of CUR more effectively, with only 55% of CUR released after 96 hours. In comparison with the free-drug solution in vivo, encapsulation of the CUR in NP63 increased mean residence time from 0.169 to 40.148 hours and the area under the concentration-time curve 4.178-fold. Conclusion: CUR was effectively entrapped by the prepared NPs, which could improve the solubility of CUR and prolong its retention in the systemic circulation.

Preparation and Pharmacodynamic Evaluation of Curcumine-Plga Nanoparticles

Preparation of PLGA-Curcumin Nanoparticles and Evaluation of Its Anti-inflammatory Properties <i>in vitro</i>

[Preparation and Pharmacodynamic Evaluation of Diammonium Glycyrrhizinate-Loaded Chitosan Nanoparticles].

Oral Nanotherapeutics with Enhanced Mucus Penetration and ROS-responsive Drug Release Capacities for Delivery of Curcumin to Colitis Tissues.

Mucus-penetrating Polymeric Nanoparticles for Oral Delivery of Curcumin to Inflamed Colon Tissue

Oral Delivery of Curcumin Via Porous Polymeric Nanoparticles for Effective Ulcerative Colitis Therapy.

Oral administration of colitis tissue-accumulating porous nanoparticles for ulcerative colitis therapy.

Oral Drug Delivery Systems for Ulcerative Colitis Therapy: A Comparative Study with Microparticles and Nanoparticles

A modified spontaneous emulsification solvent diffusion method for the preparation of curcumin-loaded PLGA nanoparticles with enhanced in vitro anti-tumor activity

Nano-in-micro alginate/chitosan hydrogel via electrospray technology for orally curcumin delivery to effectively alleviate ulcerative colitis

Real-Time Label-Free Targeting Assessment and in Vitro Characterization of Curcumin-Loaded Poly-lactic- co-glycolic Acid Nanoparticles for Oral Colon Targeting

Preparation and pharmacokinetics of curcumin nanostructured lipid carriers in rats

PLGA Nanoparticles Improve the Oral Bioavailability of Curcumin in Rats: Characterizations and Mechanisms.

Formulation, Characterization, and Evaluation of Curcumin-Loaded Ginger-Derived Nanovesicles for Anti-Colitis Activity

Curcumin-Loaded Plga-Peg-Plga Triblock Copolymeric Micelles: Preparation, Pharmacokinetics and Distribution in Vivo

Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles.

Formulation, Characterization And Evaluation Of Curcumin- Loaded PLGA- TPGS Nanoparticles For Liver Cancer Treatment

Preparation,Characteristic and Anti - tumor Activity Evaluation of Novel Curcumin Nanoparticle in vitro

N-acetyl-L-cysteine functionalized nanostructured lipid carrier for improving oral bioavailability of curcumin: preparation, in vitro and in vivo evaluations

Galactosamine-modified PEG-PLA/TPGS Micelles for the Oral Delivery of Curcumin.

Hyaluronic acid-functionalized nanoparticles for ulcerative colitis-targeted therapy: A comparative study of oral administration and intravenous injection